Erin Breese

Clinical trials

• Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  Principal investigator · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2025–2028
• Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma

  Principal investigator · Withdrawn · Phase 1

  Children's Hospital Medical Center, Cincinnati

  2018–2022
• A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  Site PI · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2025–2030
• A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  Site PI · Recruiting · Phase 2

  National Cancer Institute (NCI)

  2020–2028